Free Trial

Venus Concept (VERO) Competitors

$0.64
+0.11 (+20.75%)
(As of 07/26/2024 ET)

VERO vs. IINN, VAPO, PETV, SSKN, PSTV, PAVM, VVOS, GCTK, NURO, and AEMD

Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Inspira Technologies Oxy B.H.N. (IINN), Vapotherm (VAPO), PetVivo (PETV), STRATA Skin Sciences (SSKN), Plus Therapeutics (PSTV), PAVmed (PAVM), Vivos Therapeutics (VVOS), GlucoTrack (GCTK), NeuroMetrix (NURO), and Aethlon Medical (AEMD). These companies are all part of the "surgical & medical instruments" industry.

Venus Concept vs.

Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Venus Concept (NASDAQ:VERO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation.

Inspira Technologies Oxy B.H.N. has higher earnings, but lower revenue than Venus Concept.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies Oxy B.H.N.N/AN/A-$11.29MN/AN/A
Venus Concept$73.30M0.06-$37.25M-$6.68-0.10

12.7% of Inspira Technologies Oxy B.H.N. shares are owned by institutional investors. Comparatively, 87.4% of Venus Concept shares are owned by institutional investors. 29.4% of Inspira Technologies Oxy B.H.N. shares are owned by company insiders. Comparatively, 51.4% of Venus Concept shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Venus Concept had 1 more articles in the media than Inspira Technologies Oxy B.H.N.. MarketBeat recorded 3 mentions for Venus Concept and 2 mentions for Inspira Technologies Oxy B.H.N.. Venus Concept's average media sentiment score of 1.37 beat Inspira Technologies Oxy B.H.N.'s score of 0.41 indicating that Inspira Technologies Oxy B.H.N. is being referred to more favorably in the media.

Company Overall Sentiment
Inspira Technologies Oxy B.H.N. Positive
Venus Concept Neutral

Venus Concept received 31 more outperform votes than Inspira Technologies Oxy B.H.N. when rated by MarketBeat users. However, 100.00% of users gave Inspira Technologies Oxy B.H.N. an outperform vote while only 65.38% of users gave Venus Concept an outperform vote.

CompanyUnderperformOutperform
Inspira Technologies Oxy B.H.N.Outperform Votes
3
100.00%
Underperform Votes
No Votes
Venus ConceptOutperform Votes
34
65.38%
Underperform Votes
18
34.62%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies Oxy B.H.N.
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Venus Concept
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Inspira Technologies Oxy B.H.N. has a net margin of 0.00% compared to Inspira Technologies Oxy B.H.N.'s net margin of -51.00%. Inspira Technologies Oxy B.H.N.'s return on equity of 0.00% beat Venus Concept's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies Oxy B.H.N.N/A -158.18% -108.21%
Venus Concept -51.00%N/A -38.96%

Inspira Technologies Oxy B.H.N. has a beta of 2.05, suggesting that its share price is 105% more volatile than the S&P 500. Comparatively, Venus Concept has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500.

Summary

Venus Concept beats Inspira Technologies Oxy B.H.N. on 7 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERO vs. The Competition

MetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$4.07M$3.78B$5.28B$8.21B
Dividend YieldN/A1.62%2.79%3.96%
P/E Ratio-0.1012.07156.3217.64
Price / Sales0.0664.372,081.7286.59
Price / CashN/A49.7135.4634.13
Price / Book-0.264.244.944.51
Net Income-$37.25M$2.63M$111.50M$216.35M
7 Day Performance8.47%0.67%2.71%1.77%
1 Month Performance-21.82%5.61%11.35%7.86%
1 Year Performance-67.84%13.30%9.89%3.05%

Venus Concept Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IINN
Inspira Technologies Oxy B.H.N.
0 of 5 stars
0.00 / 5 stars
$1.06
-2.8%
N/A-29.8%$13.38MN/A0.0020Short Interest ↓
Positive News
Gap Up
VAPO
Vapotherm
0 of 5 stars
0.00 / 5 stars
$2.13
-1.4%
N/A-29.7%$13.27M$68.67M-0.25290
PETV
PetVivo
0 of 5 stars
0.00 / 5 stars
$0.65
+4.8%
N/A-69.4%$12.94M$970,000.00-0.8225
SSKN
STRATA Skin Sciences
2.6249 of 5 stars
2.62 / 5 stars
$3.30
-1.8%
$38.00
+1,051.5%
-64.1%$11.58M$33.36M-1.0099Short Interest ↓
PSTV
Plus Therapeutics
2.7134 of 5 stars
2.71 / 5 stars
$1.80
+2.9%
$8.00
+344.4%
-21.1%$10.26M$4.91M-0.5920News Coverage
PAVM
PAVmed
3.6488 of 5 stars
3.65 / 5 stars
$1.04
flat
$21.00
+1,919.2%
-81.4%$9.81M$2.45M-0.1190
VVOS
Vivos Therapeutics
0 of 5 stars
0.00 / 5 stars
$2.48
+1.6%
N/A-66.2%$8.00M$13.36M-0.23114Short Interest ↓
Positive News
Gap Down
GCTK
GlucoTrack
0 of 5 stars
0.00 / 5 stars
$1.42
+0.7%
N/A-15.6%$7.77MN/A-0.695Short Interest ↓
NURO
NeuroMetrix
0 of 5 stars
0.00 / 5 stars
$3.57
-3.5%
N/A-54.0%$7.18M$5.90M-0.5726Analyst Forecast
Gap Down
AEMD
Aethlon Medical
2.8656 of 5 stars
2.87 / 5 stars
$0.38
+8.7%
$7.00
+1,759.7%
-89.1%$5.23M$570,000.00-0.0815Short Interest ↓
News Coverage
Positive News

Related Companies and Tools

This page (NASDAQ:VERO) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners